Generating compatible translation initiation regions for heterologous gene expression in Escherichia coli by exhaustive periShine-Dalgarno mutagenesis. Human glutathione reductase cDNA as a model.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 312448)

Published in Nucleic Acids Res on June 25, 1992

Authors

U S Bücheler1, D Werner, R H Schirmer

Author Affiliations

1: Institut für Biochemie II, Universität Heidelberg, Germany.

Articles cited by this

DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54

Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res (1981) 61.59

Secondary structure of the ribosome binding site determines translational efficiency: a quantitative analysis. Proc Natl Acad Sci U S A (1990) 4.45

Inducible expression vectors incorporating the Escherichia coli atpE translational initiation region. Gene (1987) 3.46

Secondary structure of mRNA and efficiency of translation initiation. Gene (1980) 3.18

The initiation of translation in E. coli: apparent base pairing between the 16srRNA and downstream sequences of the mRNA. Nucleic Acids Res (1990) 2.81

Refined structure of glutathione reductase at 1.54 A resolution. J Mol Biol (1987) 2.60

Ribosome-messenger recognition: mRNA target sites for ribosomal protein S1. Nucleic Acids Res (1991) 2.48

Messenger RNA recognition in Escherichia coli: a possible second site of interaction with 16S ribosomal RNA. EMBO J (1988) 1.91

Glutathione-dependent synthesis of deoxyribonucleotides. Characterization of the enzymatic mechanism of Escherichia coli glutaredoxin. J Biol Chem (1979) 1.69

Glutathione reductase from Escherichia coli: cloning and sequence analysis of the gene and relationship to other flavoprotein disulfide oxidoreductases. Biochemistry (1986) 1.62

The structure of the flavoenzyme glutathione reductase. Nature (1978) 1.61

Influence of mRNA determinants on translation initiation in Escherichia coli. J Mol Biol (1991) 1.61

The path of mRNA through the Escherichia coli ribosome; site-directed cross-linking of mRNA analogues carrying a photo-reactive label at various points 3' to the decoding site. EMBO J (1991) 1.60

Codon choice and potential complementarity between mRNA downstream of the initiation codon and bases 1471-1480 in 16S ribosomal RNA affects expression of glnS. Nucleic Acids Res (1991) 1.51

Glutathione reductase from human erythrocytes. Catalytic properties and aggregation. Eur J Biochem (1976) 1.19

Isolation and mapping of glutathione reductase-negative mutants of Escherichia coli K12. J Gen Microbiol (1982) 1.03

Cloning and sequencing of mammalian glutathione reductase cDNA. Eur J Biochem (1990) 0.98

Glutathione reductase from human erythrocytes: amino-acid sequence of the structurally known FAD-binding domain. Eur J Biochem (1981) 0.97

Expression of recombinant growth hormone in Escherichia coli: effect of the region between the Shine-Dalgarno sequence and the ATG initiation codon. DNA (1989) 0.96

Redox enzyme engineering: conversion of human glutathione reductase into a trypanothione reductase. Biochemistry (1991) 0.88

Purification and characterization of lipoamide dehydrogenase from Trypanosoma cruzi. Eur J Biochem (1990) 0.87

Random silent mutagenesis in the initial triplets of the coding region: a technique for adapting human glutathione reductase-encoding cDNA to expression in Escherichia coli. Gene (1990) 0.86

Articles by these authors

A plant homolog of the neutrophil NADPH oxidase gp91phox subunit gene encodes a plasma membrane protein with Ca2+ binding motifs. Plant Cell (1998) 3.55

Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J Biol Chem (1998) 2.72

Substrate positions and induced-fit in crystalline adenylate kinase. J Mol Biol (1977) 2.69

Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers. Nat Struct Biol (1998) 2.35

Postradiation sarcomas: 20 cases and a literature review. Int J Radiat Oncol Biol Phys (1999) 1.72

Thioredoxin reductase two modes of catalysis have evolved. Eur J Biochem (2000) 1.70

Isolation of poly(A)+ RNA by paper affinity chromatography. Anal Biochem (1984) 1.69

The thioredoxin system of the malaria parasite Plasmodium falciparum. Glutathione reduction revisited. J Biol Chem (2000) 1.63

Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem (2000) 1.63

Glutathione reductase from human erythrocytes. The sequences of the NADPH domain and of the interface domain. Eur J Biochem (1982) 1.63

The structure of the flavoenzyme glutathione reductase. Nature (1978) 1.61

The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli. Proc Natl Acad Sci U S A (1997) 1.56

A human nuclear protein with sequence homology to a family of early S phase proteins is required for entry into S phase and for cell division. J Cell Sci (1994) 1.56

Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis. Ann Oncol (2012) 1.55

Synthetic inhibitors of adenylate kinases in the assays for ATPases and phosphokinases. Eur J Biochem (1975) 1.55

Restriction Analysis of PCR-Amplified Internal Transcribed Spacers of Ribosomal DNA as a Tool for Species Identification in Different Genera of the Order Glomales. Appl Environ Microbiol (1997) 1.54

Genotypic characterization of Bradyrhizobium strains nodulating endemic woody legumes of the Canary Islands by PCR-restriction fragment length polymorphism analysis of genes encoding 16S rRNA (16S rDNA) and 16S-23S rDNA intergenic spacers, repetitive extragenic palindromic PCR genomic fingerprinting, and partial 16S rDNA sequencing. Appl Environ Microbiol (1998) 1.54

Topological comparison of adenyl kinase with other proteins. Nature (1974) 1.45

Three-dimensional structure of glutathione reductase at 2 A resolution. J Mol Biol (1981) 1.32

Isoflavonoid-inducible resistance to the phytoalexin glyceollin in soybean rhizobia. J Bacteriol (1991) 1.30

Phosphodiester bonds between polypeptides and chromosomal DNA. J Mol Biol (1983) 1.25

A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase. Biochem J (1998) 1.23

The thioredoxin system of Plasmodium falciparum and other parasites. Cell Mol Life Sci (2002) 1.22

On the "activation" of cytokinins. J Biol Chem (1975) 1.22

Trypanothione reductase from Trypanosoma cruzi. Purification and characterization of the crystalline enzyme. Eur J Biochem (1987) 1.21

Chemotaxis and nod Gene Activity of Bradyrhizobium japonicum in Response to Hydroxycinnamic Acids and Isoflavonoids. Appl Environ Microbiol (1991) 1.21

Isoliquiritigenin, a strong nod gene- and glyceollin resistance-inducing flavonoid from soybean root exudate. Appl Environ Microbiol (1992) 1.20

Structural relationships in the adenylate kinase family. Eur J Biochem (1986) 1.18

[The particularities of contractile proteins of the arteries]. Biochem Z (1965) 1.18

FAD-binding site of glutathione reductase. J Mol Biol (1982) 1.18

DNA end-independent activation of DNA-PK mediated via association with the DNA-binding protein C1D. Genes Dev (1998) 1.16

Functional role of a highly repetitive DNA sequence in anchorage of the mouse genome. Nucleic Acids Res (1988) 1.14

Folding of the four domains and dimerization are impaired by the Gly446-->Glu exchange in human glutathione reductase. Implications for the design of antiparasitic drugs. Biochemistry (1993) 1.13

Tumor inhibitors. XLVII. Vernodalin and vernomygdin, two new cytotoxic sesquiterpene lactones from Vernonia amygdalina Del. J Org Chem (1969) 1.12

The enzymatic synthesis of thiophosphate analogs of nucleotides. Biochim Biophys Acta (1972) 1.11

Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS Lett (1998) 1.07

Fluorescent and spin label probes of the environments of the sulfhydryl groups of porcine muscle adenylate kinase. J Biol Chem (1975) 1.07

Analysis of the most tightly bound proteins in eukaryotic DNA. Biochim Biophys Acta (1979) 1.06

Glutathione reductase of the malarial parasite Plasmodium falciparum: crystal structure and inhibitor development. J Mol Biol (2003) 1.05

Adsorption and selection of rhizobia with ion-exchange papers. Arch Microbiol (1975) 1.02

Differentiation of Rhizobium japonicum, I. enzymatic comparison of nitrogenase repressed and derepressed free living cells and of bacteroids. Z Naturforsch C (1978) 1.00

The randomized shortened dental arch study: tooth loss over five years. Clin Oral Investig (2012) 0.99

Chemical and enzymatic analysis of covalent bonds between peptides and chromosomal DNA. Nucleic Acids Res (1991) 0.99

Glutathione reductase and glutamate dehydrogenase of Plasmodium falciparum, the causative agent of tropical malaria. Eur J Biochem (1996) 0.99

The complete cDNA sequence of mouse elongation factor 1 alpha (EF 1 alpha) mRNA. Nucleic Acids Res (1989) 0.99

[The life cycle with sexual phase in the marine diatom Coscinodiscus asteromphalus. II. Surface-dependant differentiation during the vegetative cell diminution]. Arch Mikrobiol (1971) 0.99

Cloning and sequencing of mammalian glutathione reductase cDNA. Eur J Biochem (1990) 0.98

Glutathione reductase from human erythrocytes: amino-acid sequence of the structurally known FAD-binding domain. Eur J Biochem (1981) 0.97

Redox processes in malaria and other parasitic diseases. Determination of intracellular glutathione. Histochemistry (1994) 0.97

The role of U tube palliative treatment in high bile duct carcinoma. Surgery (1988) 0.97

Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds. Eur J Biochem (1989) 0.96

Screening of isolated DNA for sequences released from anchorage sites in nuclear matrix. J Mol Biol (1985) 0.95

cDNA cloning, recombinant expression and characterization of polypetides with exceptional DNA affinity. Nucleic Acids Res (1998) 0.95

A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer. Br J Cancer (2013) 0.94

A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. J Med Chem (2001) 0.94

Antibodies to the most tightly bound proteins in eukaryotic DNA. Formation of immuno-complexes with 'nuclear matrix' components. Exp Cell Res (1984) 0.94

Deletion of the parasite-specific insertions and mutation of the catalytic triad in glutathione reductase from chloroquine-sensitive Plasmodium falciparum 3D7. Mol Biochem Parasitol (2000) 0.94

Glutathione reductase-deficient erythrocytes as host cells of malarial parasites. Biochem Pharmacol (1988) 0.94

Glutathione reductase inhibitors as potential antimalarial drugs. Effects of nitrosoureas on Plasmodium falciparum in vitro. Biochem Pharmacol (1988) 0.94

Antibodies to the most tightly bound proteins in eukaryotic DNA. Exp Cell Res (1981) 0.92

Facultatively anaerobic nitrogen-fixing bacteria from the marine environment. Can J Microbiol (1974) 0.92

Glutathione reductase from human erythrocytes. Isolation of the enzyme and sequence analysis of the redox-active peptide. Eur J Biochem (1977) 0.92

Percutaneous posterior lumbar interbody fusion using the B-twin expandable spinal spacer. Minim Invasive Neurosurg (2005) 0.91

The bacterial redox signaller pyocyanin as an antiplasmodial agent: comparisons with its thioanalog methylene blue. Redox Rep (2011) 0.91

Nucleotide sequence of the full-length mouse lamin C cDNA and its deduced amino-acid sequence. Biochim Biophys Acta (1989) 0.91

Human thioredoxin reductase is efficiently inhibited by (2,2':6',2' '-terpyridine)platinum(II) complexes. Possible implications for a novel antitumor strategy. J Med Chem (2001) 0.90

Evidence for non-deoxynucleotide linkers in Ehrlich ascites tumour cell DNA. Nature (1976) 0.90

Recombinant putative glutathione reductase of Plasmodium falciparum exhibits thioredoxin reductase activity. Mol Biochem Parasitol (1996) 0.90

Sub-set characteristics of DNA sequences involved in tight DNA/polypeptide complexes and their homology to nuclear matrix DNA. Biochem Biophys Res Commun (1987) 0.90

Urinary oxalate and urate to creatinine ratios in a healthy pediatric population. Am J Kidney Dis (1999) 0.89

Role of active site tyrosine residues in catalysis by human glutathione reductase. Biochemistry (1998) 0.89

Fragmentation of 'nuclear matrix' on a mica target. Eur J Cell Biol (1983) 0.89

Inhibition of human glutathione reductase by S-nitrosoglutathione. Eur J Biochem (1995) 0.89

Identification of human satellite DNA sequences associated with chemically resistant nonhistone polypeptide adducts. Chromosoma (1992) 0.88

Primary and tertiary structure of the principal human adenylate kinase. Eur J Biochem (1976) 0.88

Effects of dietary sucrose on factors influencing cholesterol gall stone formation. Gut (1984) 0.88

Hodgkin's disease in children. A ten-year experience in South Africa. Cancer (1984) 0.88

Carnitine plasma concentrations in 353 metabolically healthy children. Eur J Pediatr (1988) 0.87

Induction of apoptosis by overexpression of the DNA-binding and DNA-PK-activating protein C1D. J Cell Sci (1999) 0.87

Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part II: characterization of antisense oligonucleotides loaded copolymer nanoparticles. Eur J Pharm Biopharm (1999) 0.86

One single mRNA encodes the centrosomal protein CCD41 and the endothelial cell protein C receptor (EPCR). FEBS Lett (1999) 0.86

Internucleotide protein linkers in Ehrlich ascites cell DNA. Biochim Biophys Acta (1980) 0.86

Random silent mutagenesis in the initial triplets of the coding region: a technique for adapting human glutathione reductase-encoding cDNA to expression in Escherichia coli. Gene (1990) 0.86

Effects of antioxidants on glutathione levels and clinical recovery from the malnutrition syndrome kwashiorkor--a pilot study. Redox Rep (2005) 0.85

Sublines of the Ehrlich-Lettré mouse ascites tumour. A new tool for experimental cell research. Naturwissenschaften (1972) 0.85

The structural isomerisation of human-muscle adenylate kinase as studied by 1H-nuclear magnetic resonance. Eur J Biochem (1982) 0.85

Dinitrosyl-dithiol-iron complexes, nitric oxide (NO) carriers in vivo, as potent inhibitors of human glutathione reductase and glutathione-S-transferase. Biochem Pharmacol (1997) 0.85

1,3-Bis(2-chloroethyl)-1-nitrosourea as thiol-carbamoylating agent in biological systems. Methods Enzymol (1995) 0.85

Proteinase K-resistant and alkali-stably bound proteins in higher plant DNA. FEBS Lett (1980) 0.85

Kinetic characterization of glutathione reductase from the malarial parasite Plasmodium falciparum. Comparison with the human enzyme. J Biol Chem (2000) 0.85

Glomerular filtration rate: measure creatinine and height rather than cystatin C! Acta Paediatr (2003) 0.84

Distribution of 14C-TNT and derivatives in different biochemical compartments of Phaseolus vulgaris. Environ Sci Pollut Res Int (1998) 0.84

Mitochondrial adenylate kinase (AK2) from bovine heart. Homology with the cytosolic isoenzyme in the catalytic region. Eur J Biochem (1984) 0.84

Highly sensitive sites for guanine-O6 ethylation in rat brain DNA exposed to N-ethyl-N-nitrosourea in vivo. EMBO J (1984) 0.84

The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase. FEBS Lett (1997) 0.84

Inhibition of human glutathione reductase by 10-arylisoalloxazines: crystalline, kinetic, and electrochemical studies. J Med Chem (1996) 0.84

Denaturation and reactivation of dimeric human glutathione reductase--an assay for folding inhibitors. Eur J Biochem (1997) 0.84